Premise and promise of mesenchymal stem cell-based therapies in clinical vascularized composite allotransplantation.

Abstract

PURPOSE OF REVIEW Over the past decade, clinical vascularized composite allotransplantation (VCA) has enabled functional and quality of life restoration in a wide range of indications secondary to devastating tissue loss. However, the spectre of toxicity and long-term complications of chronic immunosuppression has curtailed the momentum of VCA. This study… (More)
DOI: 10.1097/MOT.0000000000000247

Topics

Cite this paper

@article{Schweizer2015PremiseAP, title={Premise and promise of mesenchymal stem cell-based therapies in clinical vascularized composite allotransplantation.}, author={Riccardo Schweizer and Vijay Gorantla and Jan A Plock}, journal={Current opinion in organ transplantation}, year={2015}, volume={20 6}, pages={608-14} }